Canada markets open in 8 hours 40 minutes
  • S&P/TSX

    20,215.12
    +50.73 (+0.25%)
     
  • S&P 500

    4,266.49
    +24.65 (+0.58%)
     
  • DOW

    34,196.82
    +322.58 (+0.95%)
     
  • CAD/USD

    0.8121
    +0.0005 (+0.06%)
     
  • CRUDE OIL

    73.42
    +0.12 (+0.16%)
     
  • BTC-CAD

    42,778.16
    +2,427.35 (+6.02%)
     
  • CMC Crypto 200

    836.12
    +49.50 (+6.29%)
     
  • GOLD FUTURES

    1,776.80
    +0.10 (+0.01%)
     
  • RUSSELL 2000

    2,333.62
    +30.15 (+1.31%)
     
  • 10-Yr Bond

    1.4870
    -1.4870 (-100.00%)
     
  • NASDAQ futures

    14,360.50
    +6.25 (+0.04%)
     
  • VOLATILITY

    15.97
    -16.32 (-100.00%)
     
  • FTSE

    7,109.97
    +35.91 (+0.51%)
     
  • NIKKEI 225

    29,079.51
    +204.28 (+0.71%)
     
  • CAD/EUR

    0.6799
    +0.0001 (+0.01%)
     

Capricor: Q1 Earnings Snapshot

·1 min read

BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $5.2 million in its first quarter.

The Beverly Hills, California-based company said it had a loss of 23 cents per share.

The biotechnology company posted revenue of $40,800 in the period. Its adjusted revenue was $41,000.

In the final minutes of trading on Thursday, the company's shares hit $3.16. A year ago, they were trading at $6.66.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting